BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gulati S, Shaughnessy J, Ram S, Rice PA. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine. Front Immunol 2019;10:321. [PMID: 30873172 DOI: 10.3389/fimmu.2019.00321] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Jackson MD, Wong SM, Akerley BJ. Underlying Glycans Determine the Ability of Sialylated Lipooligosaccharide To Protect Nontypeable Haemophilus influenzae from Serum IgM and Complement. Infect Immun 2019;87:e00456-19. [PMID: 31405955 DOI: 10.1128/IAI.00456-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
2 Scurtu LG, Jinga V, Simionescu O. Fascinating Molecular and Immune Escape Mechanisms in the Treatment of STIs (Syphilis, Gonorrhea, Chlamydia, and Herpes Simplex). Int J Mol Sci 2022;23:3550. [PMID: 35408911 DOI: 10.3390/ijms23073550] [Reference Citation Analysis]
3 Harrison OB, Maiden MC. Recent advances in understanding and combatting Neisseria gonorrhoeae: a genomic perspective. Fac Rev 2021;10:65. [PMID: 34557869 DOI: 10.12703/r/10-65] [Reference Citation Analysis]
4 Młynarczyk-Bonikowska B, Majewska A, Malejczyk M, Młynarczyk G, Majewski S. Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century. Med Microbiol Immunol 2020;209:95-108. [PMID: 31802195 DOI: 10.1007/s00430-019-00651-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Torres VVL, Coggon CF, Wells TJ. Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment. Infect Immun 2021;89:e00054-21. [PMID: 33558319 DOI: 10.1128/IAI.00054-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Del Bino L, Østerlid KE, Wu DY, Nonne F, Romano MR, Codée J, Adamo R. Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance. Chem Rev 2022. [PMID: 35608633 DOI: 10.1021/acs.chemrev.2c00021] [Reference Citation Analysis]
7 Clow F, O'Hanlon CJ, Christodoulides M, Radcliff FJ. Feasibility of Using a Luminescence-Based Method to Determine Serum Bactericidal Activity against Neisseria gonorrhoeae. Vaccines (Basel) 2019;7:E191. [PMID: 31766474 DOI: 10.3390/vaccines7040191] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Zohrabi M, Dehghan Marvast L, Izadi M, Mousavi SA, Aflatoonian B. Potential of Mesenchymal Stem Cell-Derived Exosomes as a Novel Treatment for Female Infertility Caused by Bacterial Infections. Front Microbiol 2022;12:785649. [DOI: 10.3389/fmicb.2021.785649] [Reference Citation Analysis]
9 Lin EY, Adamson PC, Klausner JD. Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions. Drugs 2021;81:1153-69. [PMID: 34097283 DOI: 10.1007/s40265-021-01530-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Maurakis SA, Cornelissen CN. Recent Progress Towards a Gonococcal Vaccine. Front Cell Infect Microbiol 2022;12:881392. [DOI: 10.3389/fcimb.2022.881392] [Reference Citation Analysis]
11 Moore SR, Menon SS, Cortes C, Ferreira VP. Hijacking Factor H for Complement Immune Evasion. Front Immunol 2021;12:602277. [PMID: 33717083 DOI: 10.3389/fimmu.2021.602277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Leduc I, Connolly KL, Begum A, Underwood K, Darnell S, Shafer WM, Balthazar JT, Macintyre AN, Sempowski GD, Duncan JA, Little MB, Rahman N, Garges EC, Jerse AE. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae. PLoS Pathog 2020;16:e1008602. [PMID: 33290434 DOI: 10.1371/journal.ppat.1008602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
13 Wanford JJ, Holmes JC, Bayliss CD, Green LR. Meningococcal core and accessory phasomes vary by clonal complex. Microb Genom 2020;6. [PMID: 32375989 DOI: 10.1099/mgen.0.000367] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Phillips ZN, Tram G, Seib KL, Atack JM. Phase-variable bacterial loci: how bacteria gamble to maximise fitness in changing environments. Biochem Soc Trans 2019;47:1131-41. [PMID: 31341035 DOI: 10.1042/BST20180633] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
15 Zhu T, McClure R, Harrison OB, Genco C, Massari P. Integrated Bioinformatic Analyses and Immune Characterization of New Neisseria gonorrhoeae Vaccine Antigens Expressed during Natural Mucosal Infection. Vaccines (Basel) 2019;7:E153. [PMID: 31627489 DOI: 10.3390/vaccines7040153] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Abisoye-Ogunniyan A, Carrano IM, Weilhammer DR, Gilmore SF, Fischer NO, Pal S, de la Maza LM, Coleman MA, Rasley A. A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections. Front Pharmacol 2021;12:768461. [PMID: 34899322 DOI: 10.3389/fphar.2021.768461] [Reference Citation Analysis]